ATC Φάρμακα Δραστικές ICPC2 ICD10 Ιατρική στην Πράξη Νοσήματα Λοιμώξεις Εμβόλια Πρωτόκολλα
  • Ceftibuten
  • indication:Used to treat acute bacterial exacerbations of chronic bronchitis (ABECB), acute bacterial otitis media, pharyngitis, and tonsilitis.
  • pharmacologypharmacology:
  • mechanism: Ceftibuten exerts its bactericidal action by binding to essential target proteins of the bacterial cell wall. This binding leads to inhibition of cell-wall synthesis.
  • toxicity: Overdosage of cephalosporins can cause cerebral irritation leading to convulsions.
  • absorprion: Rapidly absorbed following oral administration.
  • halflife:
  • roouteelimination: Ceftibuten is excreted in the urine; 95% of the administered radioactivity was recovered either in urine or feces.
  • volumedistribution: * 0.21 L/kg [adult subjects] * 0.5 L/kg [fasting pediatric patients]
  • clearance: